Jun Yuan
Impact in
- Cancer Research top 10%
- Cancer-related molecular mechanisms research
- MicroRNA in disease regulation
-
- Prostate Cancer Diagnosis and Treatment
- Prostate Cancer Treatment and Research
Papers in
-
- RNA modifications and cancer 5
-
- Renal cell carcinoma treatment 6
- Prostate Cancer Diagnosis and Treatment 6
- Prostate Cancer Treatment and Research 5
- Lung Cancer Diagnosis and Treatment 5
- Co-authors
- Zhenlei Zha (14 shared papers)Hu Zhao (9 shared papers)Bin Wu (11 shared papers)Lijin Zhang (10 shared papers)Wei Qu (4 shared papers)Lijin Zhang (2 shared papers)Tatsuo Morimura (1 shared paper)Aytaç Akbaşak (1 shared paper)
- Journals
- Frontiers in Oncology (6 papers)The International Journal of Biochemistry & Cell Biology (2 papers)International Journal of Environmental Research and Public Health (2 papers)Molecules (2 papers)Medicine (2 papers)
- Partner nations
- ChinaUnited StatesCanada
In The Last Decade
Jun Yuan
71 papers receiving 1.2k citations
Peers
Comparison fields: 5 of 127
- Cancer Research 245
- Pulmonary and Respiratory Medicine 299
- Neurology 72
- Molecular Biology 521
- Oncology 156
Countries citing papers authored by Jun Yuan
This map shows the geographic impact of Jun Yuan's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jun Yuan with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jun Yuan more than expected).
Fields of papers citing papers by Jun Yuan
This network shows the impact of papers produced by Jun Yuan. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jun Yuan. The network helps show where Jun Yuan may publish in the future.
Co-authors
The 25 scholars most cited alongside Jun Yuan, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 72 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | Interleukin-1 beta-converting enzyme mediates cisplatin-induced apoptosis in malignant glioma cells. | 1995 | 89 |
| 2 | 2018 | 80 | |
| 3 | 2018 | 78 | |
| 4 | 2018 | 62 | |
| 5 | 2016 | 59 | |
| 6 | 2022 | 58 | |
| 7 | 2018 | 51 | |
| 8 | 2018 | 51 | |
| 9 | 2018 | 48 | |
| 10 | 2018 | 39 | |
| 11 | 2018 | 38 | |
| 12 | 2019 | 33 | |
| 13 | 2004 | 32 | |
| 14 | 2019 | 32 | |
| 15 | 2016 | 23 | |
| 16 | 2015 | 23 | |
| 17 | 2021 | 23 | |
| 18 | 2016 | 22 | |
| 19 | 2017 | 21 | |
| 20 | 2016 | 21 |
About Jun Yuan
Jun Yuan is a scholar working on Molecular Biology, Pulmonary and Respiratory Medicine, Surgery, Oncology and Cancer Research, having authored 72 papers that have together received 1.2k indexed citations. Recurring topics across this work include Cancer-related molecular mechanisms research (8 papers), Bladder and Urothelial Cancer Treatments (7 papers), Renal cell carcinoma treatment (6 papers), Prostate Cancer Diagnosis and Treatment (6 papers), RNA modifications and cancer (5 papers), Prostate Cancer Treatment and Research (5 papers), Lung Cancer Diagnosis and Treatment (5 papers) and Urinary and Genital Oncology Studies (4 papers). The work is most often cited by research in Cancer Research (245 citations), Pulmonary and Respiratory Medicine (299 citations), Neurology (72 citations), Molecular Biology (521 citations) and Oncology (156 citations). Jun Yuan has collaborated with scholars based in China, United States and Canada. Frequent co-authors include Zhenlei Zha, Hu Zhao, Bin Wu, Lijin Zhang, Wei Qu, Lijin Zhang, Tatsuo Morimura, Aytaç Akbaşak, Seiji Kondo and Barbara P. Barna. Their work appears in journals such as Frontiers in Oncology, The International Journal of Biochemistry & Cell Biology, International Journal of Environmental Research and Public Health, Molecules and Medicine.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.